Busy with 3 program launches this year, Biogen trims pipeline —Novartis, helped by cost cuts, raises full-year outlook—Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO-- See more on our front page news http://bit.ly/w28kSd #earnings #biogen #novartis #jnj #consumerhealth #ipos #spinoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#earnings #biogen #novartis #jnj #consumerhealth #ipos #spinoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Pfizer pivots from early-stage rare disease R&D — Moderna caps off busy week with $1.2B CytomX collab to better target mRNA therapies —J&J's consumer health unit Kenvue files for official separation -- See more on our front page news http://bit.ly/w28kSd #pfizer #researchanddevelopment #moderna #mrna #jnj #consumerhealth #kenvue #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
#pfizer #researchanddevelopment #moderna #mrna #jnj #consumerhealth #kenvue #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
Digital health accelerator gains EU funding.
Will support 30 small companies with consumer digital health products that promote prevention, prediction and remote care.
#consumerhealth #accelerator #eu #digitalhealth